| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
ORIGINAL RESEARCH COMMUNICATION |
1 From the Departments of Nutrition (WWF, EV, GA, and DH) and Epidemiology (WWF and DH), Harvard School of Public Health, Boston, and the Departments of Community Health (GIM) and Microbiology and Immunology (SA and WU), Muhimbili University College of Health Sciences, Dar es Salaam, Tanzania
Background: In observational studies, the zinc status of HIV-infected persons has been associated with both positive and adverse clinical outcomes. Such endpoints may affect the risk of adverse birth outcomes among HIV-infected women.
Objective: We examined the effects of zinc supplements on birth outcomes, hematologic indicators, and counts of T lymphocyte subsets among 400 HIV-infected pregnant women.
Design: Eligible women between 12 and 27 wk of gestation were randomly assigned to daily oral supplementation with either 25 mg Zn or placebo between recruitment and 6 wk after delivery. All women received iron, folic acid, and multivitamin supplements irrespective of the experimental assignment.
Results: We observed no significant differences in birth weight, duration of gestation, or fetal and neonatal mortality between women in the zinc and placebo groups. Hemoglobin concentrations increased between baseline and 6 wk postpartum in both groups. However, the rise in hemoglobin over this period was significantly lower (P = 0.03) in the zinc group (
± SD: 11.5 ± 17.9 g/L) than in the placebo group (15.2 ± 18.6 g/L). Similarly, the changes in red blood cell count and in packed cell volume over the same period were significantly lower in the zinc group (P < 0.01 and P = 0.01, respectively). Zinc had no effect on CD4+, CD8+, or CD3+ cell counts during the follow-up period.
Conclusion: Because of the lack of beneficial effects of zinc on adverse pregnancy outcomes and the likelihood of negative effects on hemoglobin concentrations, no compelling evidence exists to support the addition of zinc to prenatal supplements intended for pregnant HIV-infected women.
Key Words: Zinc • HIV infection • CD4+ cells • CD8+ cells • CD3+ cells • pregnancy • birth weight • preterm infants • small-for-gestational age infants • Tanzania
This article has been cited by other articles:
|
|
 |
|
  P Christian, G L Darmstadt, L Wu, S K Khatry, S C LeClerq, J Katz, K P West Jr, and R K Adhikari The effect of maternal micronutrient supplementation on early neonatal morbidity in rural Nepal: a randomised, controlled, community trial Arch. Dis. Child., August 1, 2008; 93(8): 660 - 664. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Urassa, S. Kaaya, D. Mwakagile, M. O'Brien, G. Antelman, D. Hunter, W. Fawzi, and G. Msamanga Evidence of a substantial decline in prevalence of HIV-1 infection among pregnant women: Data from 1995 to 2003 in Dar es Salaam, Tanzania Scand J Public Health, May 1, 2006; 34(3): 272 - 278. [Abstract] [PDF]
|
|
|
|
 |
|
 E. VILLAMOR, G. MSAMANGA, S. ABOUD, W. URASSA, D. J. HUNTER, and W. W. FAWZI ADVERSE PERINATAL OUTCOMES OF HIV-1-INFECTED WOMEN IN RELATION TO MALARIA PARASITEMIA IN MATERNAL AND UMBILICAL CORD BLOOD Am J Trop Med Hyg, October 1, 2005; 73(4): 694 - 697. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Fawzi, G. Msamanga, D. Spiegelman, and D. J. Hunter Studies of Vitamins and Minerals and HIV Transmission and Disease Progression J. Nutr., April 1, 2005; 135(4): 938 - 944. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
